Body paragraph :
Tumor cells strategies to proliferate and escape in the immune checkpoints
1) Program Cell death (PD-1) and Program Cell death ligand (PD-L1)
2) Anti PD-1/PD-L1
Body paragraph :
Drugs used to inhibit the early stages of CancerDrugs
conclusion: should wrap up everything in more depth :
In general, there is growing evidence that inhibiting the interaction between Pd-1 and PD L1 can increase T-cell proliferation and can have a significant anticancer effect during immunological checkpoints. Unfortunately, owing of ignorance, carelessness, financial limitations, and religious views, early phases are frequently difficult to identify. While in some industrialized nations, early stages of cancer can be identified using a variety of methods, including diagnostic imaging, gene testing, chemotherapy, or immunotherapies. Finally, this paper’s goal was to show how the immune system faithfully carries out its duty in ludicrous and dangerous circumstances.In general, there is growing evidence that inhibiting the interaction between Pd-1 and PD L1 can increase T-cell proliferation and can have a significant anticancer effect during immunological checkpoints. Unfortunately, owing of ignorance, carelessness, financial limitations, and religious views, early phases are frequently difficult to identify. While in some industrialized nations, early stages of cancer can be identified using a variety of methods, including diagnostic imaging, gene testing, chemotherapy, or immunotherapies. Finally, this paper’s goal was to show how the immune system faithfully carries out its duty in ludicrous and dangerous circumstances.In general, there is growing evidence that inhibiting the interaction between Pd-1 and PD L1 can increase T-cell proliferation and can have a significant anticancer effect during immunological checkpoints. Unfortunately, owing of ignorance, carelessness, financial limitations, and religious views, early phases are frequently difficult to identify. While in some industrialized nations, early stages of cancer can be identified using a variety of methods, including diagnostic imaging, gene testing, chemotherapy, or immunotherapies. Finally, this paper’s goal was to show how the immune system faithfully carries out its duty in ludicrous and dangerous circumstances.
